VVA
Vida Ventures Advisors Portfolio holdings
AUM
$15.9M
This Quarter Return
-14.71%
1 Year Return
+52.49%
3 Year Return
+45.65%
5 Year Return
-49.37%
10 Year Return
–
AUM
$160M
AUM Growth
–
Cap. Flow
+$160M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
5
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Allogene Therapeutics
ALLO
|
$67.8M |
| 2 |
Dyne Therapeutics
DYN
|
$59.8M |
| 3 |
OYST
Oyster Point Pharma, Inc. Common Stock
OYST
|
$16.4M |
| 4 |
Q32 Bio
QTTB
|
$8.25M |
| 5 |
Assembly Biosciences
ASMB
|
$7.4M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Allogene Therapeutics
ALLO
$251M
| $67.8M | 42.47% |
+1,798,163
| New | +$67.8M |
|
|
2
Dyne Therapeutics
DYN
$1.92B
| $59.8M | 37.43% |
+2,960,046
| New | +$59.8M |
|
|
OYST
3
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $16.4M | 10.29% |
+778,468
| New | +$16.4M |
|
|
4
Q32 Bio
QTTB
$20.9M
| $8.25M | 5.17% |
+770,845
| New | +$8.25M |
|
|
5
Assembly Biosciences
ASMB
$190M
| $7.4M | 4.63% |
+450,000
| New | +$7.4M |
|